Urgent.News

the world's headlines, one feed

AI

Weekly Rundown: Hers rolls out new AI-native app; Novo Nordisk, H1 partner on AI-driven clinical development

The latest news from Hims & Hers, Atropos Health, Signal 1, NewYork-Presbyterian, Sharecare, Novo Nordisk, H1, Strida, Hackensack Meridian Health and ModMed.

In the week of August 3-7, Hers launched a new AI-native app offering both doctor-led and AI-driven care, with weight loss members gaining first access. The platform integrates a smart scale that tracks weight and GLP-1 progress, syncing data with healthcare providers for round-the-clock support. Hims & Hers, the company behind Hers, developed the AI tool to address the gaps in care after hours, providing personalized assistance linked to clinical protocols developed with weight-loss specialists.

By embedding intelligence throughout the care experience, Hers aims to offer expert-led, personalized support tailored to individual needs.

Written by urgent.news from Fierce Healthcare's reporting — not their text. Machine-written; read the original for the full account.

Read the original at fiercehealthcare.com →

More in AI

China’s AI Push Reshapes Its Economic Future

New Yorker staff writer Evan Osnos is on Bloomberg This Weekend and says China is taking a practical approach to AI, rapidly deploying the technology in factories and seeking to expand its use across emerging markets rather than focusing primarily on the pursuit of artificial general intelligence. (Source: Bloomberg)